Management of Endometrial Cancer
暫譯: 子宮內膜癌的管理

Mirza, Mansoor R.

Management of Endometrial Cancer
  • 出版商: Springer
  • 出版日期: 2019-09-09
  • 售價: $4,780
  • 貴賓價: 9.5 折 $4,541
  • 語言: 英文
  • 裝訂: Hardcover - also called cloth, retail trade, or trade
  • ISBN: 3319645129
  • ISBN-13: 9783319645124

    • 海外代購書籍(需單獨結帳)

相關主題

商品描述

This practical reference book provides up-to-date, evidence-based multidisciplinary guidelines on the epidemiology, biology, diagnosis, and treatment of endometrial cancer. Individual chapters focus on topics such as hormonal interactions, cancer prevention, genetic classification and its clinical applications. Recent advances in diagnostic methods are described. The treatment-oriented chapters include coverage of the roles of lymphadenectomy and sentinel node dissection, surgical complications, radiation techniques, and chemotherapy in early-stage disease. Treatment options in advanced disease, including hormonal therapy and targeted therapy, are considered separately, as is the management of rare tumor types. The authors are international key opinion leaders. Summaries of the ESMO/ESGO/ESTRO guidelines on management are included. Each clinical chapter ends with a summary of recommendations with the level of evidence.

商品描述(中文翻譯)

這本實用的參考書提供了最新的、基於證據的多學科指導方針，涵蓋了子宮內膜癌的流行病學、生物學、診斷和治療。各章節專注於如荷爾蒙相互作用、癌症預防、基因分類及其臨床應用等主題。書中描述了診斷方法的最新進展。以治療為導向的章節包括淋巴結切除術和哨兵淋巴結切除術的角色、手術併發症、放射技術以及早期疾病中的化療。對於晚期疾病的治療選擇，包括荷爾蒙療法和靶向療法，則另行考量，並且對於罕見腫瘤類型的管理也有討論。作者是國際知名的意見領袖。書中還包含了ESMO/ESGO/ESTRO管理指導方針的摘要。每個臨床章節結尾都有建議的摘要，並附上證據等級。

作者簡介

Mansoor R. Mirza is medical & radiation oncologist, involved in the management of gynaecologic cancers. He is Chief Oncologist at Rigshospitalet, Copenhagen and Medical Director of Nordic Society of Gynaecological Oncology (NSGO). His key academic goals are to promote clinical research, international trial collaboration and education. He is author and principle investigator of several phase I, II and III studies. He is chair/member of Independent Data Monitoring Committee (IDMC) of several international trials. He is co-author of ESMO-ESGO-ESTRO consensus guidelines on endometrial and vulvar cancers, senior author of national guidelines for endometrial cancer, cervical cancer, vulvar cancer and non-epithelial ovarian cancer as well as of NSGO radiotherapy guidelines. He serves in Board of Directors of Gynecologic Cancer Inter Group (GCIG) and faculty of European Society of Medical Oncology (ESMO). He also serves in Board of Directors of biotech companies like, Karyopharm

Therapeutics Inc., Metamark Genetics Inc. and Sera Prognostics Inc. He has multiple publications and book chapters and serves in editorial board or is reviewer of several journals.

 

 

作者簡介(中文翻譯)

**Mansoor R. Mirza** 是一位醫學與放射腫瘤科醫師，專注於婦科癌症的管理。他是哥本哈根的 Rigshospitalet 的首席腫瘤科醫師，以及北歐婦科腫瘤學會 (NSGO) 的醫療主任。他的主要學術目標是促進臨床研究、國際試驗合作和教育。他是多項 I、II 和 III 期研究的作者及主要研究者。他是多項國際試驗的獨立數據監測委員會 (IDMC) 的主席或成員。他是 ESMO-ESGO-ESTRO 關於子宮內膜癌和外陰癌的共識指導方針的共同作者，並且是子宮內膜癌、宮頸癌、外陰癌和非上皮性卵巢癌的國家指導方針的資深作者，以及 NSGO 放射治療指導方針的作者。他在婦科癌症跨組織 (GCIG) 的董事會中任職，並且是歐洲醫學腫瘤學會 (ESMO) 的教學成員。他還在生技公司如 Karyopharm Therapeutics Inc.、Metamark Genetics Inc. 和 Sera Prognostics Inc. 的董事會中任職。

他擁有多篇出版物和書籍章節，並在多個期刊的編輯委員會中任職或擔任審稿人。

類似商品